SCHEMBL1160897

SCHEMBL1160897

Cc1c(NS(=O)(=O)CCCC=O)sc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 1/20 0.36
▸ BRD4 O60885 2/20 0.33
▸ PFKFB3 Q16875 1/20 0.32
▸ CMA1 P23946 1/20 0.32
▸ ACLY P53396 1/20 0.32
▸ PRNP P04156 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ ACACB O00763 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ TUBB4A P04350 1/20 0.31
▸ TUBB P07437 1/20 0.31
▸ TUBA3C P0DPH7 1/20 0.31
▸ TUBA1B P68363 1/20 0.31
▸ TUBA4A P68366 1/20 0.31
▸ TUBB4B P68371 1/20 0.31
▸ TUBB3 Q13509 1/20 0.31
▸ TUBB2A Q13885 1/20 0.31
▸ TUBB8 Q3ZCM7 1/20 0.31
▸ TUBA3E Q6PEY2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11888064 0.92 HSD11B1 (0.38) HSD11B1BRD4PFKFB3CMA1ACLY
SCHEMBL2061560 0.81 HSD11B1 (0.42) HSD11B1PFKFB3CMA1ACLYPRNP
SCHEMBL2061089 0.81 HSD11B1 (0.39) HSD11B1BRD4PFKFB3CMA1ACLY
SCHEMBL1099834 0.79 HSD11B1 (0.39) HSD11B1CMA1ACLYPRNPRXFP1
SCHEMBL1148946 0.78 HSD11B1 (0.45) HSD11B1CMA1ACLYPRNPRXFP1
SCHEMBL1099719 0.76 HSD11B1 (0.41) HSD11B1CMA1ACLYPRNPRXFP1
SCHEMBL10280855 0.75 HSD11B1 (0.50) HSD11B1CMA1ACLYPRNPRXFP1
SCHEMBL18088620 0.74 KEAP1 (0.42) HSD11B1PFKFB3CMA1ACLYPRNP
SCHEMBL2061430 0.73 HSD11B1 (0.45) HSD11B1CMA1ACLYPRNPRXFP1
SCHEMBL11888065 0.70 ACLY (0.42) HSD11B1ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 — — US disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 HSD11B1 4304/4885BRD4 960/4885PFKFB3 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback